NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/09/2024
Voltar para busca
Dado oficial do USPTO
MTF BIOLOGICS. SCIENCE DRIVEN. PATIENT FOCUSED.
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MTF BIOLOGICS. SCIENCE DRIVEN. PATIENT FOCUSED.
ST13
US500000087979442Classe
5, 40, 44
Pedido
87979442
Registro
5676732
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
10/09/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 40, 44
Data de depósito
31/05/2017
Data de registro
12/02/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/09/2024
Última transação
10/09/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2018-09-00
Primeiro uso no comércio
2018-09-00
Código do desenho
4
Tipo de titular
99
Localização do titular
Edison, NJ
Examinador
DINALLO, KEVIN
Localização atual
FILE DESTROYED
Titulares e representantes
Titulares
M. F. (pessoa física)
Representantes
William W. Stroever Cole Schotz P.C.
Classificação técnica
Classes Nice
Classe 5Classe 40Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Allograft materialprocessed human bone and tissue for use in surgical or medical procedures; Allograft materialhuman bone and tissue processed into implantsscaffoldspowdersgelspastesputtymatsfilmsstripssheetsmolded piecessurgical patchesplugswound dressingswound coverings; Growth factorsproteins for promoting tissue growth and repairprocessed into surgical implantsscaffolds and plugs for the repair and replacement of human bone and tissue defects; Processed acellular human dermis and fascia tissue intended for subsequent implantation or for use in cosmetic surgery; Human allograft tissue derived from dermis; Human allograft tissue for topical use comprised of tissue from placental membranes; Human allograft tissue derived from placental tissue; Human allograft tissue derived from adipose matrix; Adipose cavity filler; Soft tissue implant for use in surgery; Bone void fillers consisting of biological materials; Bone void fillers consisting of natural materials; Cartilage implants derived from living tissue; Hydrated packaging containers specially designed for transporting and holding allograft implants made from living tissue and bone
Classe 40
Human allograft tissue processing servicespreparing biological tissue for subsequent implantation in the human body
Classe 44
Human allograft tissue bank donor services; Maintaining files and records concerning the donation of human tissue between and among the hospitaldonor and recipient; Medical services in the field of human tissuecellsbone and organ donationsobtaining donor consent and human donor referralsconducting donor screening surveyscollecting donor medical datacoordinating donor recoveries with outside entitiesproviding statistical donor data to others
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/09/2024
E815
TEAS SECTION 8 & 15 RECEIVED
26/02/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/02/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/01/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/01/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/01/2019
GNRT
NON-FINAL ACTION E-MAILED
04/01/2019
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/01/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
27/12/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
27/12/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/12/2018
IUAF
USE AMENDMENT FILED
28/11/2018
DRRR
DIVISIONAL REQUEST RECEIVED
28/11/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
28/11/2018
EISU
TEAS STATEMENT OF USE RECEIVED
28/11/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20/06/2018
EX1G
SOU EXTENSION 1 GRANTED
18/06/2018
EXT1
SOU EXTENSION 1 FILED
18/06/2018
EEXT
SOU TEAS EXTENSION RECEIVED
18/06/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/04/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/04/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
19/12/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/10/2017
PUBO
PUBLISHED FOR OPPOSITION
24/10/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/09/2017
ALIE
ASSIGNED TO LIE
18/09/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/09/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
05/09/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/09/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
05/09/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/09/2017
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/09/2017
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
01/09/2017
DOCK
ASSIGNED TO EXAMINER
29/08/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/06/2017
NWAP
NEW APPLICATION ENTERED
03/06/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MTF BIOLOGICS. SCIENCE DRIVEN. PATIENT FOCUSED. ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.